A study led by Aston University's Dr Gemma Heath and Dr Prasad Nagakumar from Birmingham Children's Hospital, has shown that treatment and diagnosis for preschool wheeze needs more effective ...

A study led by Aston University's Dr. Gemma Heath and Dr. Prasad Nagakumar from Birmingham Children's Hospital has shown that ...

Our scans show where there is patchy ventilation in patients with lung disease, and show us which parts of the lung improve ...

Objective To compare the effectiveness and safety of budesonide-glycopyrrolate-formoterol, a twice daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once daily dry powder inhaler, ...

Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration (FDA), ...

HFA-based metered-dose inhalers (MDIs) contain a propellant to deliver the medication that will continue to spray even after the medication has run out. Therefore, when the medication is gone from the ...

Asthma inhalers are hand-held devices that allow you to inhale a dose of medication to treat asthma symptoms. There are many types of asthma inhalers. They differ in whether they're used for quick ...

The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients have a treatment, in this case, a widely used inhaler, the bronchodilator, salbutamol.

A new lung scanning technique using perfluoropropane visible on MRI scans is set to revolutionize respiratory disease diagnosis and treatment. Developed by Newcastle University researchers, the ...

The new scanning technique allows the team to quantify the degree of improvement in ventilation when patients undergo treatment, in this case a widely used inhaler, the bronchodilator, salbutamol.

The Clickhaler® DPI contained 200 doses of salbutamol sulphate delivering a ... Clickhaler®, to compare it with that of the prestudy inhaler, and to assess patient technique.

Hannah Garden-Monheit, the director of the FTC's Office of Policy Planning, said in a statement that the decision was "important not only for lowering asthma inhaler costs, it also sets the stage ...